Palliative Care in Castrate-Resistant Prostate Cancer

被引:9
|
作者
Rabow, Michael W. [1 ]
Lee, Michael Xiang [2 ]
机构
[1] Univ Calif San Francisco, Helen Diller Family Comprehens Canc Ctr, Symptom Management Serv, San Francisco, CA 94143 USA
[2] Univ Calif San Francisco, Dept Med, Div Hematol Oncol, San Francisco, CA 94143 USA
关键词
Palliative care; Castrate-resistant prostate cancer; Symptom management; QUALITY-OF-LIFE; CONTROLLED-TRIAL; MEN; HOSPICE; IMPACT; SURVIVAL; OUTCOMES; SERVICE; NEEDS; END;
D O I
10.1016/j.ucl.2012.07.006
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Significant symptoms and suffering related to castrate-resistant prostate cancer (CRPC) are associated with the disease and its treatment. Increasingly, with advances in treatment efficacy, men can live with symptoms for long periods. Interdisciplinary palliative care teams (including physicians, nurses, social workers, chaplains, pharmacists, psychologists, physical therapists, and nutritionists) focused on symptom management and patients' goals of care can collaborate with prostate cancer surgeons, oncologists, and radiation oncologists to provide the best care for men at all stages of treatment, including end of life. This article reviews the benefits of palliative care in helping patients with CRPC manage symptoms and distress.
引用
收藏
页码:491 / +
页数:14
相关论文
共 50 条
  • [1] Survival and palliative care utilization among older veterans with metastatic castrate-resistant prostate cancer
    Pollock, Y. G.
    Fung, K.
    Shi, Y.
    Ngo, S.
    Walter, L. C.
    [J]. JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2020, 68 : S245 - S245
  • [2] Castrate-Resistant Prostate Cancer Foreword
    Taneja, Samir S.
    [J]. UROLOGIC CLINICS OF NORTH AMERICA, 2012, 39 (04) : XIII - XIII
  • [3] Metastatic castrate-resistant prostate cancer
    Schellhammer, Paul
    [J]. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2015, 33 (01) : 51 - 52
  • [4] Treatment of Castrate-Resistant Prostate Cancer
    Logothetis, Christopher J.
    [J]. JOURNAL OF UROLOGY, 2013, 190 (02): : 439 - 440
  • [5] Castrate-Resistant Prostate Cancer Preface
    Kibel, Adam S.
    [J]. UROLOGIC CLINICS OF NORTH AMERICA, 2012, 39 (04) : XV - XV
  • [6] Castrate-resistant prostate cancer: lessons learnt from a pilot study in the palliative care research population
    Sullivan, Karyn
    Kingi, Ngaire
    Good, Phillip
    Vayne-Bossert, Petra
    Hardy, Janet
    [J]. INTERNATIONAL JOURNAL OF PALLIATIVE NURSING, 2018, 24 (02) : 96 - 98
  • [7] Olaparib in metastatic castrate-resistant prostate cancer
    不详
    [J]. BJU INTERNATIONAL, 2020, 126 (02) : 235 - 235
  • [8] Expanding the Armamentarium for Castrate-resistant Prostate Cancer
    Waugh, David J. J.
    [J]. EUROPEAN UROLOGY, 2017, 71 (03) : 328 - 329
  • [9] Molecular Mechanisms of Castrate-Resistant Prostate Cancer
    Kotamarti, Srinath
    Armstrong, Andrew J.
    Polascik, Thomas J.
    Moul, Judd W.
    [J]. UROLOGIC CLINICS OF NORTH AMERICA, 2022, 49 (04) : 615 - 626
  • [10] Update on castrate-resistant prostate cancer: 2010
    Lassi, Kiran
    Dawson, Nancy A.
    [J]. CURRENT OPINION IN ONCOLOGY, 2010, 22 (03) : 263 - 267